Immune Checkpoints in Leukaemia as Gatekeepers of Immuno-Modulation

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• Immune evasion is a critical hallmark of cancer, enabling tumors to evade immune responses through various mechanisms.
• These mechanisms involve the modulation of immune-related cytokines, the tumor microenvironment, and immune checkpoints.
• In leukemia, immune evasion is particularly complex due to immune masking occurring alongside leukaemogenesis.

Purpose of the Study:

• To highlight the significance of leukaemic immune checkpoints in cancer survival.
• To emphasize the need for understanding these checkpoints for novel therapeutic strategies.
• To focus on the molecular and cellular components of leukaemic immune checkpoints.

Main Methods:

• Review and synthesis of current literature on immune evasion in cancer, with a specific focus on leukemia.
• Analysis of the mechanisms underlying immune checkpoint regulation in the context of leukaemogenesis.
• Identification of key molecular players, including surface molecules, receptors, ligands, and immunosuppressive cells.

Main Results:

• Leukaemic immune checkpoints represent a complex network of 'on' and 'off' switches modulating immune activity.
• Dysregulation of these checkpoints facilitates leukemia persistence, progression, and resistance to conventional therapies.
• Leukemia utilizes immune masking within the tumor microenvironment, making immune evasion a challenging hallmark.

Conclusions:

• Understanding leukaemic immune checkpoints is essential for developing effective immunomodulatory treatments.
• Targeting these checkpoints offers potential for novel therapeutic strategies in leukemia.
• Further research into the intricate interactions within the leukemia tumor environment is warranted.